Prins Video: 2 Points of Solid Reassurance regarding efficacy. These do not necessarily translate to reassurance about the business or SP end, but I like having at least one dimension tied down tightly.
1) Prins re-itterates Linda Liau's assessment of the matured, early, open label trial data to strongly indicate outstanding efficacy for the mesenchymals.
2) In Prins' presentation there is a slide that list the three most promising new cancer therapies. They are the T-Cell therapies, the Blockade Inhibitors, and DCVax(-L). I don't remember if the list shows DCVax or DCVax-L, but I think -L. This is reassuring because later Prins talks about improvements that can be made in the Dendritic approaches used so far. Based on these earlier statements he is not saying they are not great, he is just looking for the next direction for improvement. He is a researcher. That is what he does.
------------------------------------------
But Ouch! Regarding share price movement today. But the entire XBI is down hard. This is not NWBO specific.
But I feel you Afford. This silence has us all on all fours waiting for the big carrot or the big stick. It is a little uncomfortable waiting. All kinds of horrible things could be in process.... or not. I hate the blind fold. Did you feel those drops of molten wax? That is a good sign, right?
The only thing that really scares me, to be honest, is the radical change to the warrant price. I can come up with explanations where everything will still be ok soon, but it does feel like I am reaching.
So lets work on rationalizing that big warrant price change together. A group effort. How many warrants were outstanding? Ie, what was the real long term loss in financing? If the total dilution is not a large percentage then maybe this is not all that toxic.
The change makes the warrants likely converted sooner rather than later, albeit at 1/3 the gain. Maybe later is not such a big concern. Maybe she knows or strongly suspects that the extra $2 per warrant down the road would be inconsequential... down the road.
